(Q70752216)
Statements
Control of IgE responses. 4. Isotype-specific suppression of peak BPO-specific IgE antibody-forming cell responses and of BPO-specific IgE in serum by muramyldipeptide or murabutide after administration to mice by gavage (English)
D L Auci
S M Chice
M C Smith
P Dukor